Higher levels of unfractionated heparin are required for anticoagulation in the presence of a platelet collagen agonist
Publication
, Conference
Volovyk, Z; Monroe, DM; Hoffman, M
Published in: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
June 1, 2008
Duke Scholars
Published In
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN
1079-5642
Publication Date
June 1, 2008
Volume
28
Issue
6
Start / End Page
E33 / E33
Location
Atlanta, GA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Volovyk, Z., Monroe, D. M., & Hoffman, M. (2008). Higher levels of unfractionated heparin are required for anticoagulation in the presence of a platelet collagen agonist. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (Vol. 28, pp. E33–E33). Atlanta, GA: LIPPINCOTT WILLIAMS & WILKINS.
Volovyk, Zoya, Dougald M. Monroe, and Maureane Hoffman. “Higher levels of unfractionated heparin are required for anticoagulation in the presence of a platelet collagen agonist.” In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 28:E33–E33. LIPPINCOTT WILLIAMS & WILKINS, 2008.
Volovyk Z, Monroe DM, Hoffman M. Higher levels of unfractionated heparin are required for anticoagulation in the presence of a platelet collagen agonist. In: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2008. p. E33–E33.
Volovyk, Zoya, et al. “Higher levels of unfractionated heparin are required for anticoagulation in the presence of a platelet collagen agonist.” ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, vol. 28, no. 6, LIPPINCOTT WILLIAMS & WILKINS, 2008, pp. E33–E33.
Volovyk Z, Monroe DM, Hoffman M. Higher levels of unfractionated heparin are required for anticoagulation in the presence of a platelet collagen agonist. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2008. p. E33–E33.
Published In
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN
1079-5642
Publication Date
June 1, 2008
Volume
28
Issue
6
Start / End Page
E33 / E33
Location
Atlanta, GA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology